BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Taroncher-Oldenburg G, Müller C, Obermann W, Ziebuhr J, Hartmann RK, Grünweller A. Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics. Microorganisms 2021;9:540. [PMID: 33807988 DOI: 10.3390/microorganisms9030540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Obermann W, Azri MFDB, Konopka L, Schmidt N, Magari F, Sherman J, Silva LMR, Hermosilla C, Ludewig AH, Houhou H, Haeberlein S, Luo MY, Häcker I, Schetelig MF, Grevelding CG, Schroeder FC, Lau G, Taubert A, Rodriguez A, Heine A, Yeo TC, Grünweller A, Taroncher-oldenburg G. In silico, biochemical, and in vitro analysis of silvestrol binding to the DEAD box RNA helicase eIF4A reveals broad anti-pathogen potential of rocaglates across the eukaryotic tree of life.. [DOI: 10.1101/2022.09.09.507249] [Reference Citation Analysis]
2 Abdelkrim YZ, Harigua-Souiai E, Bassoumi-Jamoussi I, Barhoumi M, Banroques J, Essafi-Benkhadir K, Nilges M, Blondel A, Tanner NK, Guizani I. Enzymatic and Molecular Characterization of Anti-Leishmania Molecules That Differently Target Leishmania and Mammalian eIF4A Proteins, LieIF4A and eIF4AMus. Molecules 2022;27:5890. [PMID: 36144626 DOI: 10.3390/molecules27185890] [Reference Citation Analysis]
3 Schiffmann S, Gunne S, Ulshöfer T, Henke M, Roser LA, Schneider A, Cinatl J, Thomas D, Schreiber Y, Wagner PV, Grünweller A, Parnham MJ. In Vitro Safety, Off-Target and Bioavailability Profile of the Antiviral Compound Silvestrol. Pharmaceuticals 2022;15:1086. [DOI: 10.3390/ph15091086] [Reference Citation Analysis]
4 Obermann W, Friedrich A, Madhugiri R, Klemm P, Mengel JP, Hain T, Pleschka S, Wendel H, Hartmann RK, Schiffmann S, Ziebuhr J, Müller C, Grünweller A. Rocaglates as Antivirals: Comparing the Effects on Viral Resistance, Anti-Coronaviral Activity, RNA-Clamping on eIF4A and Immune Cell Toxicity. Viruses 2022;14:519. [DOI: 10.3390/v14030519] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Essegian DJ, Cunningham TA, Zerio CJ, Chapman E, Schatz J, Schürer SC. Molecular Dynamics Simulations Identify Tractable Lead-like Phenyl-Piperazine Scaffolds as eIF4A1 ATP-competitive Inhibitors. ACS Omega 2021;6:24432-43. [PMID: 34604625 DOI: 10.1021/acsomega.1c02805] [Reference Citation Analysis]
6 Greger H. Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from Aglaia species (Meliaceae). Phytochem Rev 2021;:1-40. [PMID: 34104125 DOI: 10.1007/s11101-021-09761-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]